Ferrets: A powerful model of SARS-CoV-2
暂无分享,去创建一个
[1] Xiaoqun Wang,et al. Single-nucleus transcriptomic profiling of multiple organs in a rhesus macaque model of SARS-CoV-2 infection , 2022, Zoological research.
[2] Hyunggee Kim,et al. SARS-CoV-2 variants show temperature-dependent enhanced polymerase activity in the upper respiratory tract and high transmissibility , 2022, bioRxiv.
[3] Troy J. Kieran,et al. Comparative Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Variants in the Ferret Model , 2022, mBio.
[4] R. Plemper,et al. SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster model , 2022, Nature Communications.
[5] R. De Francesco,et al. DNA-Vaccine-Induced Immune Response Correlates with Lower Viral SARS-CoV-2 Titers in a Ferret Model , 2022, Vaccines.
[6] A. Y. Ye,et al. Generation of a live attenuated influenza A vaccine by proteolysis targeting , 2022, Nature Biotechnology.
[7] M. Zeng,et al. Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants , 2022, Signal Transduction and Targeted Therapy.
[8] Linhui Hao,et al. Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants , 2022, bioRxiv.
[9] Q. Lin,et al. Animal models for studying coronavirus infections and developing antiviral agents and vaccines , 2022, Antiviral Research.
[10] S. Lowther,et al. Characterisation and natural progression of SARS-CoV-2 infection in ferrets , 2022, Scientific Reports.
[11] Hailiang Sun,et al. Systematic Tracing of Susceptible Animals to SARS-CoV-2 by a Bioinformatics Framework , 2022, Frontiers in Microbiology.
[12] Eun Ji Kim,et al. Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets , 2021, Nature Communications.
[13] B. Hoffmann,et al. Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta , 2021, Nature.
[14] R. Plemper,et al. Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets , 2021, Nature Communications.
[15] Mi-ha Im,et al. Antiviral effects of human placenta hydrolysate (Laennec®) against SARS-CoV-2 in vitro and in the ferret model , 2021, Journal of Microbiology.
[16] G. Ciliberto,et al. COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models , 2021, Molecular Therapy.
[17] Chang-Seon Song,et al. COVID-19 Subunit Vaccine with a Combination of TLR1/2 and TLR3 Agonists Induces Robust and Protective Immunity , 2021, Vaccines.
[18] M. H. Fernandes,et al. Age-Related Susceptibility of Ferrets to SARS-CoV-2 Infection , 2021, bioRxiv.
[19] M. Cameron,et al. Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets , 2021, Scientific Reports.
[20] N. Petrovsky,et al. Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection , 2021, bioRxiv.
[21] P. Roholl,et al. Pathology and Immunity After SARS-CoV-2 Infection in Male Ferrets Is Affected by Age and Inoculation Route , 2021, bioRxiv.
[22] R. Tripp,et al. Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo , 2021, Antiviral Research.
[23] B. Cong,et al. Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza , 2021, Signal Transduction and Targeted Therapy.
[24] W. Horman,et al. ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets , 2021, npj Vaccines.
[25] X. Qiu,et al. The Ferret as a Model for Filovirus Pathogenesis and Countermeasure Evaluation. , 2021, ILAR journal.
[26] P. Moore,et al. Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant , 2021, bioRxiv.
[27] M. Giacca,et al. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets , 2021, Nature Microbiology.
[28] J. Runstadler,et al. Host barriers to SARS-CoV-2 demonstrated by ferrets in a high-exposure domestic setting , 2021, Proceedings of the National Academy of Sciences.
[29] D. Sim,et al. Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate , 2021, Journal of virology.
[30] S. Vasan,et al. Metabolic Profiling from an Asymptomatic Ferret Model of SARS-CoV-2 Infection , 2021, Metabolites.
[31] Jae U. Jung,et al. Development of Spike Receptor-Binding Domain Nanoparticles as a Vaccine Candidate against SARS-CoV-2 Infection in Ferrets , 2021, mBio.
[32] M. Beer,et al. SARS-CoV-2 spike D614G change enhances replication and transmission , 2021, Nature.
[33] R. Plemper,et al. 4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication , 2021, Science.
[34] F. Gleeson,et al. ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models , 2021, Communications biology.
[35] C. Turner,et al. Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity , 2021, Nature Communications.
[36] I. Brown,et al. Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human Infection , 2021, Viruses.
[37] Eun Ji Kim,et al. Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission , 2021, Emerging microbes & infections.
[38] T. Bestebroer,et al. SARS-CoV and SARS-CoV-2 are transmitted through the air between ferrets over more than one meter distance , 2020, Nature Communications.
[39] R. Plemper,et al. Therapeutically Administered Ribonucleoside Analogue MK-4482/EIDD-2801 Blocks SARS-CoV-2 Transmission in Ferrets , 2020, Nature microbiology.
[40] C. Alabi,et al. Intranasal fusion inhibitory lipopeptide prevents direct contact SARS-CoV-2 transmission in ferrets , 2020, bioRxiv.
[41] M. Mohan,et al. Animal Models for SARS-CoV-2 research: A Comprehensive Literature Review. , 2020, Transboundary and emerging diseases.
[42] Xiaohong Song,et al. A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge , 2020, Nature Communications.
[43] Yong-tang Zheng,et al. Delayed severe cytokine storm and immune cell infiltration in SARS-CoV-2-infected aged Chinese rhesus macaques , 2020, Zoological research.
[44] Chengbo He,et al. Single‐cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID‐19 infection , 2020, Molecular genetics & genomic medicine.
[45] Yong-tang Zheng,et al. COVID-19-like symptoms observed in Chinese tree shrews infected with SARS-CoV-2 , 2020, Zoological research.
[46] R. Fonseca,et al. Targeting TMPRSS2 in SARS-CoV-2 Infection , 2020, Mayo Clinic Proceedings.
[47] W. Zuo,et al. Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2 , 2020, American journal of respiratory and critical care medicine.
[48] Sharon J Peacock,et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. , 2020, JAMA.
[49] Zhe Zheng,et al. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart , 2020, Cardiovascular research.
[50] Tokiko Watanabe,et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development , 2020, Proceedings of the National Academy of Sciences.
[51] Rongchang Chen,et al. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment , 2020, Cell.
[52] G. Gao,et al. Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2 , 2020, Cell.
[53] Eric Song,et al. Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling , 2020, bioRxiv.
[54] T. Zhao,et al. A Mouse Model of SARS-CoV-2 Infection and Pathogenesis , 2020, Cell Host & Microbe.
[55] H. Gao,et al. Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 via Close Contact and Respiratory Droplets Among Human Angiotensin-Converting Enzyme 2 Mice , 2020, The Journal of Infectious Diseases.
[56] Eun Ji Kim,et al. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets , 2020, mBio.
[57] P. Zhou,et al. Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2 , 2020, Cell.
[58] H. Yen,et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters , 2020, Nature.
[59] M. Koopmans,et al. SARS-CoV-2 is transmitted via contact and via the air between ferrets , 2020, bioRxiv.
[60] T. Kuiken,et al. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model , 2020, Science.
[61] Baoying Huang,et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2 , 2020, Science.
[62] Eun-Ha Kim,et al. Infection and Rapid Transmission of SARS-CoV-2 in Ferrets , 2020, Cell Host & Microbe.
[63] K. To,et al. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[64] A. Walls,et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.
[65] Wenling Wang,et al. Age‐related rhesus macaque models of COVID‐19 , 2020, Animal models and experimental medicine.
[66] A. Schuchat,et al. COVID-19: towards controlling of a pandemic , 2020, The Lancet.
[67] P. Zhou,et al. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques , 2020, Cell Research.
[68] B. Graham,et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.
[69] Wenling Wang,et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice , 2020, Nature.
[70] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[71] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[72] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[73] A. García-Sastre,et al. Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection , 2020, Emerging microbes & infections.
[74] T. Maines,et al. Ferreting Out Influenza Virus Pathogenicity and Transmissibility: Past and Future Risk Assessments in the Ferret Model. , 2019, Cold Spring Harbor perspectives in medicine.
[75] R. Plemper,et al. Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia , 2019, Science Translational Medicine.
[76] S. Kent,et al. Improving immunological insights into the ferret model of human viral infectious disease , 2019, Influenza and other respiratory viruses.
[77] Fang Li,et al. Structure, Function, and Evolution of Coronavirus Spike Proteins. , 2016, Annual review of virology.
[78] A. Osterhaus,et al. Ferrets as a Novel Animal Model for Studying Human Respiratory Syncytial Virus Infections in Immunocompetent and Immunocompromised Hosts , 2016, Viruses.
[79] S. van Drunen Littel-van den Hurk,et al. Pathogenesis of respiratory syncytial virus. , 2012, Current opinion in virology.
[80] John M. Walker,et al. Metabolic Profiling , 2011, Methods in Molecular Biology.
[81] David K Meyerholz,et al. Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. , 2010, The Journal of clinical investigation.
[82] T. Kuiken,et al. Pathology of Experimental SARS Coronavirus Infection in Cats and Ferrets , 2008, Veterinary pathology.
[83] G. Navis,et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.
[84] J. Bartlett. Virology: SARS virus infection of cats and ferrets , 2004 .
[85] A. Konstantinos,et al. A Comparative Assessment , 2003 .
[86] G. Prince,et al. The pathogenesis of respiratory syncytial virus infection in infant ferrets. , 1976, The American journal of pathology.